Sanjay Kumar, PhD

About

Cell & molecular biologist with expertise bridging experimental cancer biology, centrosome biology, and computational drug discovery. Currently investigating PLK1-driven procentriole maturation using in vivo crosslinking mass spectrometry at the NCI/NIH. Prior work spans siRNA-based therapeutic targeting of oncogenic transcription factors in lung cancer and multi-target virtual screening for antiviral drug candidates. Experienced in high-resolution microscopy, proteomics workflows, cell cycle analysis, and structure-based drug design across viral and cancer disease models.

Employment

• National Institutes of Health Postdoctoral Visiting Fellow
  2023 - Present
• Jawaharlal Nehru University Ph. D. Scholar
  2018 - 2023

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (6)

• siRNA-based Therapeutic Candidate Targeting PRDM2 for Inhibition of Lung Cancer Progression
  2025 DOI: 10.1101/2025.02.06.636957
  +Save
• Computational assessment of Withania somnifera phytomolecules as putative inhibitors of Mycobacterium tuberculosis CTP synthase PyrG
  Journal of Biomolecular Structure and Dynamics 2023 DOI: 10.1080/07391102.2022.2074142
  +Save
• Viral informatics: bioinformatics-based solution for managing viral infections
  Briefings in Bioinformatics 2022 DOI: 10.1093/bib/bbac326
  +Save
• Pharmacophore-Model-Based Drug Repurposing for the Identification of the Potential Inhibitors Targeting the Allosteric Site in Dengue Virus NS5 RNA-Dependent RNA Polymerase
  Viruses 2022 DOI: 10.3390/v14081827
  +Save
• Promising Antiviral Activities of Natural Flavonoids against SARS-CoV-2 Targets: Systematic Review
  International Journal of Molecular Sciences 2021 DOI: 10.3390/ijms222011069
  +Save
• Discovery of Bispecific Lead Compounds From Azadirachta Indica Against ZIKA NS2B-NS3 Protease and RNA Dependent RNA Polymerase Using Molecular Simulations
  DOI: 10.20944/preprints202203.0328.v1
  +Save